Activation of the complement system by high dose immunotherapy with recombinant IL 2: Relation to the development of side effects

L.G. Thijs, C.E. Hack, R.J.M. Strack van Schijndel, J.H. Nuijens, G.J. Wolbin, A.J.M. Eerenberg-Belmer, H. van der Valk, J. Wagstaff, H.M. Pinedo

Research output: Contribution to journalArticleAcademicpeer-review

7 Downloads (Pure)
Original languageEnglish
Pages (from-to)2419-2424
JournalThe Journal of Immunology
Volume144
Publication statusPublished - 1990

Cite this